NASDAQ · RMTI
Rockwell Medical, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for RMTI: Nov 12, 2026
Rockwell Medical, Inc. Common Stock is expected to report earnings on 11/12/2026 before market open. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 1 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.13. The reported EPS for the same quarter last year was $-0.5.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.13 | $-0.13 | $-0.13 | 1 |
| Dec 2026 | $-0.07 | $-0.07 | $-0.07 | 1 |
| Mar 2027 | $0.02 | $0.02 | $0.02 | 1 |
| Jun 2027 | $0.08 | $0.08 | $0.08 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
The Motley Fool · Zacks- The Motley Fool · Aug 13, 10:59 PM EDTRockwell Medical (RMTI) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Zacks · Aug 13, 7:10 AM EDTRockwell Medical (RMTI) Reports Q2 Loss, Lags Revenue EstimatesRockwell Medical (RMTI) delivered earnings and revenue surprises of -100.00% and -0.34%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Aug 10, 8:15 AM EDTVillage Farms (VFF) Q2 Earnings and Revenues Beat EstimatesVillage Farms (VFF) delivered earnings and revenue surprises of +200.00% and +13.99%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Aug 6, 10:00 AM EDTRockwell Medical (RMTI) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseRockwell Medical (RMTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks · Aug 5, 5:10 PM EDTCuraleaf Holdings, Inc. (CURLF) Q2 Earnings and Revenues Surpass EstimatesCuraleaf Holdings, Inc. (CURLF) delivered earnings and revenue surprises of +125.00% and +2.44%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Jul 14, 5:10 PM EDTKestra Medical Technologies, Ltd. (KMTS) Reports Q4 Loss, Tops Revenue EstimatesKestra Medical Technologies, Ltd. (KMTS) delivered earnings and revenue surprises of -13.56% and +8.05%, respectively, for the quarter ended April 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Jun 30, 1:07 PM EDTDaVita Stock Benefits From Strengthening Kidney Care DeliveryDVA is advancing kidney care through IKC expansion, CMS CKCC progress and AI-driven dialysis scheduling improvements.
- Zacks · Jun 10, 12:54 PM EDTDaVita Stock Gains From Integrated Kidney Care and CKCC ProgressDVA expands its IKC platform, tops CKCC savings in first-quarter 2026 and rolls out AI ScheduleHub to boost scheduling and staffing.
- The Motley Fool · May 8, 11:11 AM EDTRMTI Q1 2026 Earnings Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Zacks · May 7, 7:10 AM EDTRockwell Medical (RMTI) Reports Q1 Loss, Misses Revenue EstimatesRockwell Medical (RMTI) delivered earnings and revenue surprises of -300.00% and -7.29%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Apr 30, 3:40 PM EDTVerano Holdings Corp. (VRNO) Reports Q1 Loss, Tops Revenue EstimatesVerano Holdings Corp. (VRNO) delivered earnings and revenue surprises of +15.79% and +3.82%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Mar 27, 9:40 AM EDTShould Value Investors Buy Rockwell Medical (RMTI) Stock?Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Rockwell Medical, Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.